Robert Weisman

Weisman covers the healthcare and life sciences industries for the Business section. He was a business reporter and editor for the Hartford Courant and the Seattle Times before joining the Globe in 2000.

Latest stories

Mass Innovation Labs targets smaller startups

By , Globe Staff

The Cambridge operator of biotech research space is preparing to add six new “innovation suites” for smaller companies.

Agios targets immuno-oncology after Celgene deal

By , Globe Staff

The Cambridge biotech will search for drugs that stimulate the human body’s immune response against cancer cells.

Ariad shrinks its board of directors

By , Globe Staff

The move could make it easier for the Cambridge biotech to respond quickly to a potential takeover offer.

Baker funds $63.6m for life sciences capital projects

By , Globe Staff

Administration officials have made good on a commitment to the Massachusetts Life Sciences Center.